Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Common Stock Issued (2021 - 2025)

Updated

Context Therapeutics (CNTX) posted Common Stock Issued of $15,268 for Q4 2025, down 99.9% from $14.54 million a year earlier.

Analysis

Context Therapeutics (CNTX) Common Stock Issued (2021 - 2025) Analysis & Trends

For FY2024, Context Therapeutics' Common Stock Issued came in at $109.29 million.

  • Annual Common Stock Issued shows a three-year compound annual growth rate of 27.0% (FY2021 to FY2024).
  • In prior years, Context Therapeutics' Common Stock Issued was $53.41 million in FY2021.
  • Quarterly Common Stock Issued has run from a low of -$102,071 in Q1 2022 to a high of $94.8 million in Q2 2024 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 50,000.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 743.00 Mn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 247.00 Mn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 87.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Context Therapeutics 15.24 Mn -182.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 15,268.00
Mar 31, 2025 -15,268.00
Dec 31, 2024 14.54 Mn
Sep 30, 2024 -44,632.00
Jun 30, 2024 94.80 Mn
Dec 31, 2022 102,071.00
Mar 31, 2022 -102,071.00
Dec 31, 2021 53.41 Mn
API Access

Context Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=CNTX&period=max&api_key=YOUR_API_KEY